Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-07-22 00:00:00 ET · period of report 2024-07-18 · accession 0001649094-24-000038 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-07-22 | 2024-07-18 | PCVX | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $81.17 | -8,000 | 99.1K | -7% | -$649.4K |
| D | 2024-07-22 | 2024-07-18 | PCVX | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +8,000 | 104.7K | +8% | +$42.8K |
| D | 2024-07-22 | 2024-07-18 | PCVX | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $0.00 | -8,000 | 336.8K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-18 | S | D | 3,095 | $80.12 | 101,625 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $79.61 to $80.59. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-07-18 | S | D | 926 | $83.14 | 96,720 | D | — | — | (F5) The price reported is a weighted-average price. The shares were sold at prices ranging from $82.69 to $83.36. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-07-18 | S | D | 1,479 | $82.32 | 97,646 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $81.68 to $82.655. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-07-18 | M | A | 8,000 | $5.35 | 104,720 | D | — | — | |
| 5 | Common | Common Stock | 2024-07-18 | S | D | 2,500 | $81.06 | 99,125 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $80.65 to $81.625. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 6 | Derivative | Stock Option (right to buy) | 2024-07-18 | M | D | 8,000 | $0.00 | 336,827 | D | $5.35 · — to 2030-05-11 | 8,000 Common Stock | (F6) 1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter. |